Pembrolizumab plus platinum-based chemotherapy has demonstrated efficacy as first-line treatment for advanced penile cancer in a phase 2 trial. The results were published in JAMA Oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback